FibroGen (FGEN) Reports China FDA Acceptance of Roxadustat New Drug Application (NDA)
Tweet Send to a Friend
FibroGen, Inc. (NASDAQ: FGEN) today announced that the China Food and Drug Administration (CFDA) has accepted the company’s recently submitted ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
